RGLS

Regulus Therapeutics Inc.

NASDAQHealthcareBiotechnologyUS

USD8.16

+0.00 (+0.00%)

CEO

Joseph P. Hagan

IPO Date

2012-10-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$8.16

Prev. Close

$8.16

Day Low

$8.16

Day High

$8.16

52W Low

$0.83

52W High

$8.35

Market Cap

$0.56B

Volume

8.76M

News SentimentNeutral

Articles

Avg Positive

10.4%

Avg Negative

2.4%

Avg Neutral

87.1%

News Feed

Regulus Therapeutics Presents Additional Data From Rare Kidney Disease Program

Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Connect 2021

Regulus Therapeutics to Present Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Connect 2021